X-RAD SmART Cancer Radiotherapy System

The X-RAD SmART system is Australia's first state of the art small animal radiotherapy system.

Supported by BHP Billiton, Ian Potter Foundation, Chris and Tia Ellison, Telethon Adventurers and Tour de Cure, this platform creates new and unique opportunities for radiation oncology research in Australia supporting pre-clinical research that aims to understand the effects of radiation on normal and cancer cells, explore new treatment options and develop new cross-disciplinary collaborations.

The system uses image guidance to precisely deliver radiation to tumours in small animals. CT imaging enables 3D guidance to precisely target radiation therapy in real time. The system also incorporates a full integrated Bioluminescent Imaging Platform to allow for precise tumour localization. SmART plan software is the treatment planning system used to calculate dose, provide beam planning, dose calculation and visualization tools to enable researchers to accurately plan, visualize and optimize treatment dose prior to therapy.

Specifications

• Dual Focus X-ray: 225kV, 20mA
• Dose Rates: 1->600cGy/min
• 2 Beam Filters: 2mm Al and 0.3mm Cu Filter
• Image Guided Targeting Precision up to 30 um
• CT imaging Resolution up to 100µm
• Fully integrated bioluminescence imaging platform
• 360o rotation of the system around the subject
• A suite of collimators ranging in sizes from 2.5 mm to 40mm (circular and square)
• Pilot Image Acquisition and Reconstruction Software
• SmART Plan Treatment Planning System

Further reading: X-RAD media release